Virtual Dermatology for Vitiligo

Patients with non-segmental vitiligo aged 12 and older can consult dermatologists virtually for treatment options. Opsalura ruxolitinib cream is presented as a topical solution that aids in skin repigmentation, allowing patients to initiate their treatment promptly. Virtual consultations provide increased convenience by eliminating the need for in-person visits while maintaining patient access to specialists. It is necessary for patients to check the suitability of Opsalura considering potential interactions with other biopharmaceuticals or immunosuppressants.